Diabetes and Insulin- physiology focus Flashcards
what do islet of langerhan secrete into circulation
insulin (beta cells), glucagon (alpha cells), somatostatin (delta cells), pancreatic polypeptide (PP cells)
glucagon purpose
regulates carbohydrate, fat, protein metabolism
insulin purpose
regulates carbohydrate, fat, protein metabolism
somatostatin purpose
suppresses growth hormone release
pancreatic polypeptide purpose
self-regulate pancreatic secretion activities (endocrine and exocrine)
insulin daily levels, half life, metabolism, binding site
daily 40-50 units secreted
t1/2 5min
metabolism: liver and kidneys (80%)
binds to extracellular alpha subunits, intracellular beta subunits
insulin MOA
binds to extracellular domain -> conformational change of alpha subunits -> facilitates ATP binding to beta subunits ->phosphorylation ->mediates enzyme activation, inactivation and metabolic signaling
insulin genetic makeup
51 amino acid peptide hormone synthesized in beta cells of islets of langerhans as single polypeptide proinsulin, precursor molecule to insulin. proinsulin converted to insulin and c peptide.
what reflects functional activity of pancreatic beta cells
plasma concentrations of insulin and c peptide
glucagon stimulates and inhibits
stimulates glycogenolysis (breakdown of glucose) and gluconeogenesis (glucose formation) and inhibits glycolysis
insulin released in response to
beta adrenergic stimulation or acetylcholine
what stimulates insulin release (drugs and metabolic environments)
hyperglycemia, beta agonists, acetylcholine, glucagon
what inhibits insulin release (drugs and metabolic environments)
hypoglycemia, beta antagonists, alpha agonists, somatostatin, diazoxide, thiazide diuretics, volatile anesthetics, insulin)
glucagon
catabolic hormone that mobilizes fatty acids, amino acids into systemic circulation. principle stimulation for secretion is hypoglycemia. activates adenylate cyclase for cAMP formation. exogenous admin can lead to enhanced myocardial contractility. elimination t 1/2 3-6min
IV Insulin t1/2, metabolism, renal considerations
elimination t1/2 5-10min
metabolized in kidneys and liver by proteolytic enzyme. 50% of insulin that reaches liver through portal vein is metabolized.
renal dysfx alters circulating insulin levels more than hepatic disease.
peripheral tissue (skeletal, muscle, fat) can bind to, inactivate insulin
insulin SQ duration
30-60min (tightly bound to tissue receptors).
insulin anesthetic implications
preoperative morbidity related to preexisting end organ damage
preop chest X-ray may show cardiac enlargement, pulmonary vascular congestion, pleural effusion
increased incidence of ST segment or T wave abnormalities
myocardial ischemia or old infarction may be found on ECG
DM + HTN = 50% likelihood of diabetic autonomic neuropathy
periop CV problems increased with use of ACEI or ARB
diabetic renal dysfx: elevated creatinine and CKD
gastroparesis and insulin anesthetic implications
premedicate with nonparticulate acid and metoclopramide. risk factors, old age, DM for greater than 10 years, CAD, BB
glycolysation implication
implies limited mobility of joints, ask them to perform the prayer sign. temporomandibular joint and cervical spine mobility should be assessed preoperatively in diabetic patients to assess for risk of difficult intubation
hyperglycemia anesthetic implications
associated with hyperrosmolarity, infection, poor wound healing, increased mortality.
anesthesia management of diabetic patients
patient takes 2/3 of nighttime insulin (NPH, regular) and 1/2 total morning insulin dose of NPH but regular insulin dose for AM should be held
pump: decrease overnight rate by 30% and keep at basal rate for DOS
if patient takes glargine and lispro/aspart daily, take 2/3 glargine dose and entire lispro/aspart night before. hold AM dosing.
add regular insulin to NS in 1 unit/ml conc and begin at .2-1units/kg/hour. target <180mg/dL
how to calculate intraop insulin rate
regular insulin units/hour = plasma glucose/150
1 unit of insulin usually lowers plasma glucose by
25-30mg/dL
anesthesia management: sulfonylureas and metformin
have long half lives, d/c 24-48h before surgery